Cassone M - Search Results

1

Synergy between a lead proline-rich antibacterial peptide derivative and small molecule antibiotics.

Otvos L Jr, Cassone M, Inacio VO, Noto P, Rux JJ, Wade JD, Cudic P. Otvos L Jr, et al. Among authors: cassone m. Adv Exp Med Biol. 2009;611:375-8. doi: 10.1007/978-0-387-73657-0_165. Adv Exp Med Biol. 2009. PMID: 19400232 No abstract available.

2

Scope and limitations of the designer proline-rich antibacterial peptide dimer, A3-APO, alone or in synergy with conventional antibiotics.

Cassone M, Vogiatzi P, La Montagna R, De Olivier Inacio V, Cudic P, Wade JD, Otvos L Jr. Cassone M, et al. Peptides. 2008 Nov;29(11):1878-86. doi: 10.1016/j.peptides.2008.07.016. Epub 2008 Aug 5. Peptides. 2008. PMID: 18721837

3

Agonists and partial antagonists acting on the leptin--leptin receptor interface.

Otvos L Jr, Cassone M, Terrasi M, Cascio S, Mateo GD, Knappe D, Hoffmann R, Cudic P, Wade JD, Surmacz E. Otvos L Jr, et al. Among authors: cassone m. Adv Exp Med Biol. 2009;611:497-8. doi: 10.1007/978-0-387-73657-0_215. Adv Exp Med Biol. 2009. PMID: 19400282 No abstract available.

4

Synergy among antibacterial peptides and between peptides and small-molecule antibiotics.

Cassone M, Otvos L Jr. Cassone M, et al. Expert Rev Anti Infect Ther. 2010 Jun;8(6):703-16. doi: 10.1586/eri.10.38. Expert Rev Anti Infect Ther. 2010. PMID: 20521897 Review.

5

Alternative stabilities of a proline-rich antibacterial peptide in vitro and in vivo.

Noto PB, Abbadessa G, Cassone M, Mateo GD, Agelan A, Wade JD, Szabo D, Kocsis B, Nagy K, Rozgonyi F, Otvos L Jr. Noto PB, et al. Among authors: cassone m. Protein Sci. 2008 Jul;17(7):1249-55. doi: 10.1110/ps.034330.108. Epub 2008 Apr 15. Protein Sci. 2008. PMID: 18413862 Free PMC article.

6

Development of a pharmacologically improved peptide agonist of the leptin receptor.

Otvos L Jr, Terrasi M, Cascio S, Cassone M, Abbadessa G, De Pascali F, Scolaro L, Knappe D, Stawikowski M, Cudic P, Wade JD, Hoffmann R, Surmacz E. Otvos L Jr, et al. Among authors: cassone m. Biochim Biophys Acta. 2008 Oct;1783(10):1745-54. doi: 10.1016/j.bbamcr.2008.05.007. Epub 2008 May 21. Biochim Biophys Acta. 2008. PMID: 18555805 Free article.

7

The antibacterial effect of a proline-rich antibacterial peptide A3-APO.

Rozgonyi F, Szabo D, Kocsis B, Ostorházi E, Abbadessa G, Cassone M, Wade JD, Otvos L Jr. Rozgonyi F, et al. Among authors: cassone m. Curr Med Chem. 2009;16(30):3996-4002. doi: 10.2174/092986709789352295. Curr Med Chem. 2009. PMID: 19747127 Review.

8

Peptide-based leptin receptor antagonists for cancer treatment and appetite regulation.

Otvos L Jr, Kovalszky I, Scolaro L, Sztodola A, Olah J, Cassone M, Knappe D, Hoffmann R, Lovas S, Hatfield MP, Beko G, Zhang S, Wade JD, Surmacz E. Otvos L Jr, et al. Among authors: cassone m. Biopolymers. 2011;96(2):117-25. doi: 10.1002/bip.21377. Biopolymers. 2011. PMID: 20564005

9

HIF-1alpha and STAT3 client proteins interacting with the cancer chaperone Hsp90: therapeutic considerations.

Kim HL, Cassone M, Otvos L Jr, Vogiatzi P. Kim HL, et al. Among authors: cassone m. Cancer Biol Ther. 2008 Jan;7(1):10-4. doi: 10.4161/cbt.7.1.5458. Epub 2007 Dec 21. Cancer Biol Ther. 2008. PMID: 18347418 Free article. Review.

10

The designer proline-rich antibacterial peptide A3-APO is effective against systemic Escherichia coli infections in different mouse models.

Szabo D, Ostorhazi E, Binas A, Rozgonyi F, Kocsis B, Cassone M, Wade JD, Nolte O, Otvos L Jr. Szabo D, et al. Among authors: cassone m. Int J Antimicrob Agents. 2010 Apr;35(4):357-61. doi: 10.1016/j.ijantimicag.2009.10.015. Epub 2009 Dec 23. Int J Antimicrob Agents. 2010. PMID: 20031377

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters